Steris (STE) Issues FY 2019 Earnings Guidance

Steris (NYSE:STE) issued an update on its FY 2019 earnings guidance on Monday morning. The company provided EPS guidance of $4.74-4.84 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.76. The company issued revenue guidance of $2.751-2.751 billion, compared to the consensus revenue estimate of $2.75 billion.

NYSE:STE traded up $1.27 on Monday, hitting $119.86. The stock had a trading volume of 772,423 shares, compared to its average volume of 413,651. The firm has a market cap of $10.03 billion, a P/E ratio of 28.88 and a beta of 1.04. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.01 and a current ratio of 2.63. Steris has a 52 week low of $83.44 and a 52 week high of $121.67.

A number of research firms have recently weighed in on STE. KeyCorp raised their target price on Steris from $120.00 to $132.00 and gave the company an overweight rating in a report on Tuesday, November 13th. Zacks Investment Research restated a buy rating and issued a $132.00 target price on shares of Steris in a report on Friday, November 16th. Finally, Sidoti raised their target price on Steris from $155.00 to $157.00 and gave the company a buy rating in a report on Thursday, December 6th. Five investment analysts have rated the stock with a buy rating, The stock currently has a consensus rating of Buy and a consensus target price of $134.20.

In other news, VP John Adam Zangerle sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, January 25th. The stock was sold at an average price of $115.00, for a total value of $345,000.00. Following the transaction, the vice president now owns 33,796 shares in the company, valued at $3,886,540. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.38% of the stock is owned by company insiders.

ILLEGAL ACTIVITY NOTICE: “Steris (STE) Issues FY 2019 Earnings Guidance” was originally published by WKRB News and is the sole property of of WKRB News. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The correct version of this piece of content can be read at https://www.wkrb13.com/2019/02/12/steris-ste-issues-fy-2019-earnings-guidance.html.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Story: Day Trading

Earnings History and Estimates for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply